Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands
OBJECTIVESSpinal muscular atrophy (SMA) is a rare genetic disorder that causes progressive muscle weakness and paralysis. In its most common and severe form, the majority of untreated infants die before 2 years of age. Early detection and treatment, ideally before symptom onset, maximize survival an...
Saved in:
Published in: | Value in health Vol. 25; no. 10; pp. 1696 - 1704 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
01-10-2022
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!